Mediwound Stock Analysis

MDWD Stock  USD 9.70  0.45  4.86%   
The latest Mediwound price dip may encourage shareholders to take a closer look at the firm as it is trading at a share price of 9.70 on 11,570 in trading volume. The company directors and management were unable to exploit market volatilities in May. However, diversifying your overall positions with Mediwound can protect your principal portfolio during market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 2.87. The current volatility is consistent with the ongoing market swings in May 2023 as well as with Mediwound unsystematic, company-specific events.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mediwound. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in banks. For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.
The main objective of Mediwound stock analysis is to determine its intrinsic value, which is an estimate of what Mediwound is worth, separate from its market price. There are two main types of Mediwound's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Mediwound's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Mediwound's stock to identify patterns and trends that may indicate its future price movements.
The Mediwound stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Mediwound is usually not traded on Christmas Day, Thanksgiving Day, Christmas Day ( substitute day ), New Year 's Monday, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Veterans Day ( substitute day ). Mediwound Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Mediwound's ongoing operational relationships across important fundamental and technical indicators.

Mediwound Stock Analysis Notes

About 24.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 3.47. Mediwound had not issued any dividends in recent years. The entity had 1:7 split on the 20th of December 2022. MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel. Mediwound operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 77 people. To find out more about Mediwound contact Cal Cohen at 972 7 797 14100 or learn more at

Mediwound Quarterly Cost of Revenue

2.97 Million

Mediwound Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Mediwound's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Mediwound or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Mediwound generated a negative expected return over the last 90 days
Mediwound is unlikely to experience financial distress in the next 2 years
The company reported the previous year's revenue of 26.5 M. Net Loss for the year was (19.6 M) with profit before overhead, payroll, taxes, and interest of 13.16 M.
Mediwound currently holds about 10.41 M in cash with (11.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31.
Roughly 24.0% of the company outstanding shares are owned by corporate insiders
Latest headline from Analyst Forecasts Just Became More Bearish On MediWound Ltd.

Mediwound Upcoming and Recent Events

Earnings reports are used by Mediwound to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Mediwound previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
8th of August 2023
Upcoming Quarterly Report
21st of November 2023
Next Financial Report
30th of June 2023
Next Fiscal Quarter End
21st of March 2024
Next Fiscal Year End
31st of March 2023
Last Quarter Report
31st of December 2022
Last Financial Announcement

Mediwound Largest EPS Surprises

Earnings surprises can significantly impact Mediwound's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates
View All Earnings Estimates

Mediwound SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Mediwound prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Mediwound investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Mediwound specific information freely available to individual and institutional make a timely investment decision.
31st of May 2023
Other Events
30th of May 2023
Other Events
9th of May 2023
Other Events
20th of April 2023
Other Events
16th of March 2023
Other Events
14th of February 2023
Unclassified Corporate Event
13th of February 2023
Other Events. Unclassified Corporate Event
8th of February 2023
Unclassified Corporate Event

Mediwound Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Mediwound is soaring high without any particular reason? This is usually happening because many institutional investors.are aggressively trading Mediwound backward and forwards among themselves. Mediwound's institutional investor refers to the entity that pools money to purchase Mediwound's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Last TransactionTypeSharesValue
Point72 Asset Management Lp2023-03-31Common Shares821.5 K10.9 M
Dafna Capital Management Llc2023-03-31Common Shares257.7 K3.4 M
Armistice Capital Llc2022-09-30Common Shares1.9 M2.7 M
Alyeska Investment Group Lp2023-03-31Common Shares150 KM
Awm Investment Company Inc2023-03-31Common Shares142.9 K1.9 M
Sphera Funds Management Ltd2023-03-31Common Shares111.1 K1.5 M
Sargent Investment Group Llc2023-03-31Common Shares100.8 K1.4 M
Uniplan Investment Counsel Inc2023-03-31Common Shares98.2 K1.3 M
Wells Fargo Company2023-03-31Common Shares97.2 K1.3 M
Renaissance Technologies Llc2023-03-31Common Shares56.8 K757 K
Essex Investment Management Co Llc2023-03-31Common Shares54.6 K727.4 K
Note, although Mediwound's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Mediwound Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 83.38 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Mediwound's market, we take the total number of its shares issued and multiply it by Mediwound's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Mediwound Profitablity

Mediwound's profitability indicators refer to fundamental financial ratios that showcase Mediwound's ability to generate income relative to its revenue or operating costs. If, let's say, Mediwound is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Mediwound's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Mediwound's profitability requires more research than a typical breakdown of Mediwound's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.74) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.28) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.28.
Last ReportedProjected for 2023
Return on Average Assets(0.62) (0.67) 
Return on Average Equity(6.38) (6.89) 
Return on Invested Capital(1.84) (1.98) 
Return on Sales(0.32) (0.34) 

Management Efficiency

Mediwound has return on total asset (ROA) of (0.1336) % which means that it has lost $0.1336 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (6.1905) %, meaning that it created substantial loss on money invested by shareholders. Mediwound's management efficiency ratios could be used to measure how well Mediwound manages its routine affairs as well as how well it operates its assets and liabilities. As of June 6, 2023, Return on Average Assets is expected to decline to -0.67. In addition to that, Return on Average Equity is expected to decline to -6.89. Mediwound Goodwill and Intangible Assets are projected to decrease significantly based on the last few years of reporting. The past year's Goodwill and Intangible Assets were at 231,000. The current year's Asset Turnover is expected to grow to 0.91, whereas Current Assets are forecasted to decline to about 43.3 M.
Last ReportedProjected for 2023
Book Value per Share 2.19  2.36 
Enterprise Value over EBIT(8.00) (8.21) 
Enterprise Value over EBITDA(9.47) (9.72) 
Price to Book Value 7.19  6.65 
Tangible Assets Book Value per Share 9.98  10.04 
Enterprise Value67 M73.5 M
Tangible Asset Value49.8 M47.7 M
The analysis of Mediwound's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Mediwound's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Mediwound Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Non Current Liabilities Total
27 M
Short Long Term Debt Total
846 K
Interest Expense
8.9 M
Total Operating Expenses
21.5 M

Technical Drivers

As of the 6th of June, Mediwound secures the risk adjusted performance of (0.12), and Mean Deviation of 2.09. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mediwound, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We are able to interpolate and break down nineteen technical drivers for Mediwound, which can be compared to its peers in the industry. Please verify Mediwound treynor ratio, and the relationship between the standard deviation and downside variance to decide if Mediwound is priced some-what accurately, providing market reflects its recent price of 9.7 per share. Given that Mediwound has jensen alpha of (0.35), we recommend you to check Mediwound's last-minute market performance to make sure the company can sustain itself at a future point.

Mediwound Price Movement Analysis

The output start index for this execution was twenty-nine with a total number of output elements of thirty-two.

Mediwound Predictive Daily Indicators

Mediwound intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Mediwound stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Mediwound Forecast Models

Mediwound's time-series forecasting models are one of many Mediwound's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mediwound's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Mediwound Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Mediwound prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Mediwound shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Mediwound. By using and applying Mediwound Stock analysis, traders can create a robust methodology for identifying Mediwound entry and exit points for their positions.
Last ReportedProjected for 2023
EBITDA Margin(0.27) (0.29) 
Gross Margin 0.50  0.54 
Profit Margin(0.74) (0.80) 

Current Mediwound Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Mediwound analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Mediwound analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
33.16Strong Buy6Odds
Mediwound current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Mediwound analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Mediwound stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Mediwound, talking to its executives and customers, or listening to Mediwound conference calls.
Mediwound Analyst Advice Details

Mediwound Stock Analysis Indicators

Mediwound stock analysis indicators help investors evaluate how Mediwound stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Mediwound shares will generate the highest return on investment. By understating and applying Mediwound stock analysis, traders can identify Mediwound position entry and exit signals to maximize returns.
Begin Period Cash Flow11 M
Common Stock Shares OutstandingM
Total Stockholder Equity10.9 M
Tax Provision78 K
Property Plant And Equipment Net3.6 M
Cash And Short Term Investments33.9 M
Cash33.9 M
Accounts Payable5.7 M
Net Debt-33 M
50 Day M A11.3371
Total Current Liabilities12.1 M
Other Operating Expenses34.8 M
Non Current Assets Total4.2 M
Non Currrent Assets Other364 K
Stock Based Compensation1.9 M
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mediwound. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in banks. For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for Mediwound Stock analysis

When running Mediwound's price analysis, check to measure Mediwound's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mediwound is operating at the current time. Most of Mediwound's value examination focuses on studying past and present price action to predict the probability of Mediwound's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mediwound's price. Additionally, you may evaluate how the addition of Mediwound to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
CEO Directory
Screen CEOs from public companies around the world
CEO Directory
Screen CEOs from public companies around the world
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Is Mediwound's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mediwound. If investors know Mediwound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mediwound listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
Return On Equity
The market value of Mediwound is measured differently than its book value, which is the value of Mediwound that is recorded on the company's balance sheet. Investors also form their own opinion of Mediwound's value that differs from its market value or its book value, called intrinsic value, which is Mediwound's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mediwound's market value can be influenced by many factors that don't directly affect Mediwound's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mediwound's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mediwound is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mediwound's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.